The GI Tract's Neuroendocrine Satiety System: Complete 2007 Review

The complete neuroendocrine satiety system involves gut peptides (GLP-1, PYY, CCK, oxyntomodulin, ghrelin), enteric neural signaling, and central integration — with gut peptide-based drugs as the most promising obesity pharmacotherapy.

Maljaars, J et al.·Alimentary pharmacology & therapeutics·2007·Moderate EvidenceReview
RPEP-01267ReviewModerate Evidence2007RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Review
Evidence
Moderate Evidence
Sample
Not reported

What This Study Found

GI neuroendocrine satiety regulation integrates gut peptide signals (GLP-1, PYY, CCK, oxyntomodulin, ghrelin), enteric neural pathways, and central melanocortin/NPY circuits for comprehensive food intake control — gut peptide drugs leading the obesity treatment pipeline.

Key Numbers

How They Did This

review study on neuropeptides, glp-1.

Why This Research Matters

Relevant for neuropeptides, glp-1, weight-loss.

The Bigger Picture

Advances peptide research.

What This Study Doesn't Tell Us

See abstract.

Questions This Raises

  • ?Further research needed.
  • ?Clinical translation to evaluate.

Trust & Context

Key Stat:
Key finding GI neuroendocrine satiety regulation integrates gut peptide signals (GLP-1, PYY, CCK, oxyntomodulin, ghrelin), enteric neural pathways, and central me
Evidence Grade:
moderate evidence.
Study Age:
Published in 2007.
Original Title:
Review article: The gastrointestinal tract: neuroendocrine regulation of satiety and food intake.
Published In:
Alimentary pharmacology & therapeutics, 26 Suppl 2, 241-50 (2007)
Database ID:
RPEP-01267

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study

Summarizes existing research on a topic.

What do these levels mean? →

Frequently Asked Questions

What was studied?

The GI Tract's Neuroendocrine Satiety System: Complete 2007 Review

What was found?

The complete neuroendocrine satiety system involves gut peptides (GLP-1, PYY, CCK, oxyntomodulin, ghrelin), enteric neural signaling, and central integration — with gut peptide-based drugs as the most promising obesity pharmacotherapy.

Read More on RethinkPeptides

Cite This Study

RPEP-01267·https://rethinkpeptides.com/research/RPEP-01267

APA

Maljaars, J; Peters, H P F; Masclee, A M. (2007). Review article: The gastrointestinal tract: neuroendocrine regulation of satiety and food intake.. Alimentary pharmacology & therapeutics, 26 Suppl 2, 241-50. https://doi.org/10.1111/j.1365-2036.2007.03550.x

MLA

Maljaars, J, et al. "Review article: The gastrointestinal tract: neuroendocrine regulation of satiety and food intake.." Alimentary pharmacology & therapeutics, 2007. https://doi.org/10.1111/j.1365-2036.2007.03550.x

RethinkPeptides

RethinkPeptides Research Database. "Review article: The gastrointestinal tract: neuroendocrine r..." RPEP-01267. Retrieved from https://rethinkpeptides.com/research/maljaars-2007-review-article-the-gastrointestinal

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.